We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ATXI Avenue Therapeutics Inc

-0.012 (-5.66%)
After Hours
Last Updated: 17:29:54
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Avenue Therapeutics Inc ATXI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.012 -5.66% 0.20 17:29:54
Open Price Low Price High Price Close Price Prev Close
0.1896 0.18 0.2106 0.192 0.212
more quote information »

Recent News

Date Time Source Heading
12/01/202308:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
11/28/202316:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/28/202316:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/24/202313:19EDGAR2Form 8-K - Current report
11/13/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202316:10EDGAR2Form 8-K - Current report
11/13/202316:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
11/02/202316:10EDGAR2Form 8-K - Current report
11/02/202315:00GLOBEAvenue Therapeutics Announces Closing of $5.0 Million Public..
11/02/202309:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
11/01/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
10/31/202309:15GLOBEAvenue Therapeutics Announces Pricing of $5.0 Million Public..
10/05/202317:05EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
9/29/202317:23EDGAR2Form S-1/A - General form for registration of securities..
9/28/202316:25EDGAR2Form 8-K - Current report
9/27/202316:03EDGAR2Form 8-K - Current report
9/18/202317:18EDGAR2Form S-1 - General form for registration of securities under..
9/08/202316:15EDGAR2Form 8-K - Current report
9/05/202308:30GLOBEAvenue Therapeutics to Present at H.C. Wainwright 25th..
8/14/202316:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
8/11/202316:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:20EDGAR2Form 8-K - Current report
8/10/202316:15GLOBEAvenue Therapeutics Reports Second Quarter 2023 Financial..
8/01/202308:30GLOBEAvenue Therapeutics Announces High Potency and Full Efficacy..
7/27/202308:30GLOBEAvenue Therapeutics Announces First Patient Dosed in Phase..
7/25/202308:30GLOBEAvenue Therapeutics Announces Agreement with the FDA on the..
7/21/202316:37EDGAR2Form 8-K - Current report
7/05/202316:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/05/202316:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/05/202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/03/202313:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/28/202316:56EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
5/15/202316:01GLOBEFortress Biotech Reports First Quarter 2023 Financial..
5/12/202308:30GLOBEAvenue Therapeutics Reports First Quarter 2023 Financial..
4/27/202308:30GLOBEAvenue Therapeutics to Present at Aegis Capital Virtual..
4/17/202316:01GLOBEAvenue Therapeutics Announces Regulatory Update Based on..
3/30/202316:10GLOBEFortress Biotech Reports Record 2022 Financial Results and..
3/30/202316:01GLOBEAvenue Therapeutics Reports Full Year 2022 Financial Results..
3/08/202316:01GLOBEAvenue Therapeutics Provides Regulatory Update on IV..
3/02/202308:00GLOBEAvenue Therapeutics Enters into a Transformational License..
1/31/202313:09GLOBEAvenue Therapeutics Announces Closing of $3.25 Million..
1/27/202311:58GLOBEAvenue Therapeutics Announces $3.25 Million Registered..

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |